IN-DATE
60-02: SentreHeart SofTIP Guide Cannula and Dilator
Sign in to add this product to your favorites!
| Price: | $24.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 3 box of 1 |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 11 hours 13 minutes and choose overnight shipping at checkout. |
Additional Details
SofTIP Guide Cannula
60-02
- SofTIP Guide Cannula, Long, 13F
- 13F Dilator
The SofTIP Guide Cannula is designed to provide control during delivery and placement of the LARIAT Suture Delivery Device. Using advances in braided catheter technology integrated with an atraumatic tip design, the low profile SofTIP enables guidance and orientation of the LARIAT through a 4.3mm access for positioning at the targeted closure location.
- Diameter: 4.3mm (12.9F)
- Working Length: 22.5cm
- Overall Length: 25cm
AccessGUDID Info
- FDA Product Code: GAT
- FDA Product Code Name: Suture, Nonabsorbable, Synthetic, Polyethylene
- GMDN Term Code: 64565
- GMDN Term Name: Pericardioscopic access cannula
- GMDN Term Description: A rigid, single-lumen, surgical instrument intended to be percutaneously inserted through the chest and through the pericardial cavity to facilitate the introduction of surgical instruments as part of a minimally-invasive cardiac procedure (e.g., epicardial ablation). It is intended for subxiphoid or transdiaphragmatic access, and once in place is intended to remain in position for the duration of the procedure. It may include a trocar blade intended to assist introduction. This is a single-use device.
Manufacturer
AtriCure is a leading provider of innovative technologies for the treatment of Atrial Fibrillation (Afib) and related conditions. Electrophysiologists and cardiothoracic surgeons around the globe count on AtriCure to deliver best-in-class solutions that can treat even the most complex cases. The Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. The AtriClip Left Atrial Appendage Exclusion System products are the most widely used LAA management devices worldwide. The Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients, and the cryoICE cryoSPHERE® probe is cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures.
